1 1

FreeStyle Libre

FreeStyle Libre 14 Day Flash Glucose Monitoring System

PRODUCT HIGHLIGHTS

  • Accurate - The most accurate 14-day Continuous Glucose Monitoring system to help reduce time spent in hypoglycemia and improve overall glucose control.

  • Discreet - The world’s smallest, thinnest, and most discreet sensor—smaller than two stacked pennies.

  • Easy - Painless to apply and wear with a simple 1-piece applicator.

  • Reliable - Optional, real-time glucose alarms let you know the minute your glucose is too high or too low.
  • Fast Delivery
  • Auto Delivery , Free Shipping For $100 Above Products
Item Description Quantity Price
FreeStyle Libre 14 Day
FreeStyle Libre 14 day system as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision, resulting in injury. 1 Each

Price:$133.99
View full details

Description

Intermittent scanning CGM for diabetes self-management. Measures glucose levels in interstitial fluid via a small sensor placed on the back of the upper arm. Glucose data is displayed when the sensor is scanned with the reader.

Key Features

  • 14-Day Wear – Sensor lasts up to two weeks without calibration.

  • Factory-Calibrated – No fingerstick calibration required.

  • Trend Data – Displays 8-hour glucose history and trend arrows.

  • Quick Scanning – Get results in seconds by scanning the sensor with the reader or compatible device.

  • Discreet & Comfortable – Slim, water-resistant sensor can be worn during everyday activities.

Technical Overview

Specification Details
Type Flash Glucose Monitoring System (Intermittent Scanning CGM)
Sensor Placement Posterior upper arm
Wear Duration Up to 14 days
Calibration Factory calibrated – no SMBG calibration needed
Alarms None (scan to view readings)
Trend Display 8-hour glucose history
Accuracy Mean Absolute Relative Difference: 11.4% (adults), 13.9% (children)
FDA Approval Year 2017
Water Resistance Yes, up to 1 meter for 30 minutes

Clinical Performance

  • Accuracy: Stable over 14 days; slightly reduced during hypoglycemia, post-glucose load, and exercise.

  • Glycemic Impact:

    • Systematic review (n=2,477) found CGMs improved time in range by ~70 min/day and reduced hypo- and hyperglycemia compared to SMBG.

    • Meta-analysis (n=2,173) found A1C reduction of −0.26% from baseline; not statistically significant compared with SMBG.